本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Biodesix, Inc.

6.62
+0.620010.33%
成交量:21.36萬
成交額:137.98萬
市值:5,163.60萬
市盈率:-1.18
高:6.75
開:5.95
低:5.91
收:6.00
52周最高:34.40
52周最低:3.44
股本:780.00萬
流通股本:339.60萬
量比:0.25
換手率:6.29%
股息:- -
股息率:- -
每股收益(TTM):-5.5983
每股收益(LYR):-6.6216
淨資產收益率:-219.68%
總資產收益率:-20.81%
市淨率:45.37
市盈率(LYR):-1.00

資料載入中...

2024/05/08

重要事件披露

Form 8-K - Current report
2024/04/23

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/04/09

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/09

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/09

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/09

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/09

重要事件披露

Form 8-K - Current report
2024/03/01

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/20

重要事件披露

Form 8-K - Current report
2023/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08

重要事件披露

Form 8-K - Current report
2023/08/11

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities